nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrochlorothiazide—CA5B—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0736	0.186	CbGpPWpGaD
Hydrochlorothiazide—CA12—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0682	0.172	CbGpPWpGaD
Hydrochlorothiazide—CA4—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0544	0.137	CbGpPWpGaD
Hydrochlorothiazide—CA2—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0521	0.132	CbGpPWpGaD
Hydrochlorothiazide—CA1—Reversible hydration of carbon dioxide—CA7—colon cancer	0.05	0.126	CbGpPWpGaD
Hydrochlorothiazide—CA9—Reversible hydration of carbon dioxide—CA7—colon cancer	0.044	0.111	CbGpPWpGaD
Hydrochlorothiazide—CA9—gall bladder—colon cancer	0.0137	0.1	CbGeAlD
Hydrochlorothiazide—KCNMA1—blood vessel—colon cancer	0.0112	0.0821	CbGeAlD
Hydrochlorothiazide—KCNMA1—gall bladder—colon cancer	0.0106	0.0773	CbGeAlD
Hydrochlorothiazide—Diclofenamide—CA7—colon cancer	0.00906	0.388	CrCbGaD
Hydrochlorothiazide—Hydroflumethiazide—CA7—colon cancer	0.00765	0.328	CrCbGaD
Hydrochlorothiazide—SLC12A3—renal system—colon cancer	0.00734	0.0536	CbGeAlD
Hydrochlorothiazide—Trichlormethiazide—CA7—colon cancer	0.00663	0.284	CrCbGaD
Hydrochlorothiazide—KCNMA1—epithelium—colon cancer	0.00547	0.04	CbGeAlD
Hydrochlorothiazide—CA9—digestive system—colon cancer	0.0054	0.0394	CbGeAlD
Hydrochlorothiazide—KCNMA1—smooth muscle tissue—colon cancer	0.00527	0.0385	CbGeAlD
Hydrochlorothiazide—CA2—gall bladder—colon cancer	0.00521	0.038	CbGeAlD
Hydrochlorothiazide—KCNMA1—renal system—colon cancer	0.00507	0.0371	CbGeAlD
Hydrochlorothiazide—CA12—renal system—colon cancer	0.00487	0.0355	CbGeAlD
Hydrochlorothiazide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—EP300—colon cancer	0.00403	0.0102	CbGpPWpGaD
Hydrochlorothiazide—CA12—digestive system—colon cancer	0.00399	0.0292	CbGeAlD
Hydrochlorothiazide—CA1—renal system—colon cancer	0.00385	0.0282	CbGeAlD
Hydrochlorothiazide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—colon cancer	0.00382	0.00965	CbGpPWpGaD
Hydrochlorothiazide—CA2—embryo—colon cancer	0.0033	0.0241	CbGeAlD
Hydrochlorothiazide—CA1—lymphoid tissue—colon cancer	0.0032	0.0234	CbGeAlD
Hydrochlorothiazide—CA1—digestive system—colon cancer	0.00316	0.0231	CbGeAlD
Hydrochlorothiazide—CA5B—vagina—colon cancer	0.00316	0.0231	CbGeAlD
Hydrochlorothiazide—KCNMA1—liver—colon cancer	0.0031	0.0227	CbGeAlD
Hydrochlorothiazide—CA4—renal system—colon cancer	0.00301	0.022	CbGeAlD
Hydrochlorothiazide—CA1—bone marrow—colon cancer	0.00291	0.0213	CbGeAlD
Hydrochlorothiazide—CA9—HIF-1-alpha transcription factor network—HNF4A—colon cancer	0.00288	0.00729	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—TOP1—colon cancer	0.0028	0.00708	CbGpPWpGaD
Hydrochlorothiazide—CA2—epithelium—colon cancer	0.00269	0.0197	CbGeAlD
Hydrochlorothiazide—CA2—smooth muscle tissue—colon cancer	0.0026	0.019	CbGeAlD
Hydrochlorothiazide—CA2—renal system—colon cancer	0.0025	0.0183	CbGeAlD
Hydrochlorothiazide—CA4—digestive system—colon cancer	0.00247	0.0181	CbGeAlD
Hydrochlorothiazide—KCNMA1—lymph node—colon cancer	0.00238	0.0174	CbGeAlD
Hydrochlorothiazide—CA1—liver—colon cancer	0.00236	0.0172	CbGeAlD
Hydrochlorothiazide—CA4—bone marrow—colon cancer	0.00228	0.0166	CbGeAlD
Hydrochlorothiazide—CA2—lymphoid tissue—colon cancer	0.00207	0.0152	CbGeAlD
Hydrochlorothiazide—CA2—digestive system—colon cancer	0.00205	0.015	CbGeAlD
Hydrochlorothiazide—CA5B—lymph node—colon cancer	0.00204	0.0149	CbGeAlD
Hydrochlorothiazide—CA2—bone marrow—colon cancer	0.00189	0.0138	CbGeAlD
Hydrochlorothiazide—CA2—vagina—colon cancer	0.00181	0.0132	CbGeAlD
Hydrochlorothiazide—CA1—lymph node—colon cancer	0.00181	0.0132	CbGeAlD
Hydrochlorothiazide—CA9—HIF-1-alpha transcription factor network—ABCB1—colon cancer	0.0018	0.00455	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular response to hypoxia—EP300—colon cancer	0.00178	0.0045	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular response to hypoxia—VEGFA—colon cancer	0.00169	0.00426	CbGpPWpGaD
Hydrochlorothiazide—CA2—liver—colon cancer	0.00153	0.0112	CbGeAlD
Hydrochlorothiazide—CA5B—Metabolism—CA7—colon cancer	0.0015	0.00378	CbGpPWpGaD
Hydrochlorothiazide—CA4—lymph node—colon cancer	0.00141	0.0103	CbGeAlD
Hydrochlorothiazide—CA12—Metabolism—CA7—colon cancer	0.00139	0.0035	CbGpPWpGaD
Hydrochlorothiazide—CA2—lymph node—colon cancer	0.00117	0.00855	CbGeAlD
Hydrochlorothiazide—CA4—Metabolism—CA7—colon cancer	0.00111	0.00279	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—CA7—colon cancer	0.00106	0.00268	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—CA7—colon cancer	0.00102	0.00257	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—TYMS—colon cancer	0.000986	0.00249	CbGpPWpGaD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—PTGS2—colon cancer	0.000924	0.00233	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—CHST5—colon cancer	0.000906	0.00229	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—ODC1—colon cancer	0.000906	0.00229	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—CA7—colon cancer	0.000893	0.00226	CbGpPWpGaD
Hydrochlorothiazide—Malaise—Irinotecan—colon cancer	0.000881	0.00198	CcSEcCtD
Hydrochlorothiazide—Vertigo—Irinotecan—colon cancer	0.000878	0.00198	CcSEcCtD
Hydrochlorothiazide—Dysuria—Capecitabine—colon cancer	0.000877	0.00198	CcSEcCtD
Hydrochlorothiazide—Neutropenia—Capecitabine—colon cancer	0.000877	0.00198	CcSEcCtD
Hydrochlorothiazide—Syncope—Irinotecan—colon cancer	0.000876	0.00197	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Irinotecan—colon cancer	0.000874	0.00197	CcSEcCtD
Hydrochlorothiazide—Upper respiratory tract infection—Capecitabine—colon cancer	0.000872	0.00196	CcSEcCtD
Hydrochlorothiazide—Anaemia—Fluorouracil—colon cancer	0.000865	0.00195	CcSEcCtD
Hydrochlorothiazide—Loss of consciousness—Irinotecan—colon cancer	0.000859	0.00193	CcSEcCtD
Hydrochlorothiazide—Dermatitis exfoliative—Methotrexate—colon cancer	0.000857	0.00193	CcSEcCtD
Hydrochlorothiazide—Photosensitivity reaction—Capecitabine—colon cancer	0.000856	0.00193	CcSEcCtD
Hydrochlorothiazide—Myalgia—Vincristine—colon cancer	0.000854	0.00192	CcSEcCtD
Hydrochlorothiazide—Weight increased—Capecitabine—colon cancer	0.000854	0.00192	CcSEcCtD
Hydrochlorothiazide—Visual disturbance—Methotrexate—colon cancer	0.000853	0.00192	CcSEcCtD
Hydrochlorothiazide—Cough—Irinotecan—colon cancer	0.000852	0.00192	CcSEcCtD
Hydrochlorothiazide—Hyperglycaemia—Capecitabine—colon cancer	0.000846	0.00191	CcSEcCtD
Hydrochlorothiazide—Pneumonia—Capecitabine—colon cancer	0.000841	0.00189	CcSEcCtD
Hydrochlorothiazide—CA12—Metabolism—ODC1—colon cancer	0.00084	0.00212	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—CHST5—colon cancer	0.00084	0.00212	CbGpPWpGaD
Hydrochlorothiazide—Leukopenia—Fluorouracil—colon cancer	0.000837	0.00189	CcSEcCtD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—CCND1—colon cancer	0.000834	0.00211	CbGpPWpGaD
Hydrochlorothiazide—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000829	0.00187	CcSEcCtD
Hydrochlorothiazide—Acute coronary syndrome—Capecitabine—colon cancer	0.000825	0.00186	CcSEcCtD
Hydrochlorothiazide—Renal failure—Capecitabine—colon cancer	0.000822	0.00185	CcSEcCtD
Hydrochlorothiazide—Discomfort—Irinotecan—colon cancer	0.000822	0.00185	CcSEcCtD
Hydrochlorothiazide—Neuropathy peripheral—Capecitabine—colon cancer	0.00082	0.00185	CcSEcCtD
Hydrochlorothiazide—Myocardial infarction—Capecitabine—colon cancer	0.00082	0.00185	CcSEcCtD
Hydrochlorothiazide—CA9—HIF-1-alpha transcription factor network—EP300—colon cancer	0.000819	0.00207	CbGpPWpGaD
Hydrochlorothiazide—Anaphylactic shock—Vincristine—colon cancer	0.000819	0.00184	CcSEcCtD
Hydrochlorothiazide—Oedema—Vincristine—colon cancer	0.000819	0.00184	CcSEcCtD
Hydrochlorothiazide—Jaundice—Capecitabine—colon cancer	0.000815	0.00184	CcSEcCtD
Hydrochlorothiazide—Conjunctivitis—Capecitabine—colon cancer	0.000813	0.00183	CcSEcCtD
Hydrochlorothiazide—Urinary tract infection—Capecitabine—colon cancer	0.000813	0.00183	CcSEcCtD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—CDKN1A—colon cancer	0.000807	0.00204	CbGpPWpGaD
Hydrochlorothiazide—Confusional state—Irinotecan—colon cancer	0.000804	0.00181	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Vincristine—colon cancer	0.000802	0.0018	CcSEcCtD
Hydrochlorothiazide—Haematuria—Capecitabine—colon cancer	0.000798	0.0018	CcSEcCtD
Hydrochlorothiazide—Oedema—Irinotecan—colon cancer	0.000797	0.0018	CcSEcCtD
Hydrochlorothiazide—Anaphylactic shock—Irinotecan—colon cancer	0.000797	0.0018	CcSEcCtD
Hydrochlorothiazide—Chest pain—Fluorouracil—colon cancer	0.000797	0.00179	CcSEcCtD
Hydrochlorothiazide—Myalgia—Fluorouracil—colon cancer	0.000797	0.00179	CcSEcCtD
Hydrochlorothiazide—Hyperhidrosis—Vincristine—colon cancer	0.000791	0.00178	CcSEcCtD
Hydrochlorothiazide—Epistaxis—Capecitabine—colon cancer	0.000789	0.00178	CcSEcCtD
Hydrochlorothiazide—Discomfort—Fluorouracil—colon cancer	0.000787	0.00177	CcSEcCtD
Hydrochlorothiazide—Shock—Irinotecan—colon cancer	0.000784	0.00177	CcSEcCtD
Hydrochlorothiazide—Agranulocytosis—Capecitabine—colon cancer	0.000781	0.00176	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Irinotecan—colon cancer	0.000781	0.00176	CcSEcCtD
Hydrochlorothiazide—Anorexia—Vincristine—colon cancer	0.00078	0.00176	CcSEcCtD
Hydrochlorothiazide—CA9—HIF-1-alpha transcription factor network—VEGFA—colon cancer	0.000776	0.00196	CbGpPWpGaD
Hydrochlorothiazide—Hyperhidrosis—Irinotecan—colon cancer	0.000771	0.00174	CcSEcCtD
Hydrochlorothiazide—Confusional state—Fluorouracil—colon cancer	0.00077	0.00173	CcSEcCtD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—EP300—colon cancer	0.000768	0.00194	CbGpPWpGaD
Hydrochlorothiazide—Mood swings—Methotrexate—colon cancer	0.000766	0.00172	CcSEcCtD
Hydrochlorothiazide—Hypotension—Vincristine—colon cancer	0.000765	0.00172	CcSEcCtD
Hydrochlorothiazide—Bradycardia—Capecitabine—colon cancer	0.000765	0.00172	CcSEcCtD
Hydrochlorothiazide—Anaphylactic shock—Fluorouracil—colon cancer	0.000764	0.00172	CcSEcCtD
Hydrochlorothiazide—Oedema—Fluorouracil—colon cancer	0.000764	0.00172	CcSEcCtD
Hydrochlorothiazide—Anorexia—Irinotecan—colon cancer	0.00076	0.00171	CcSEcCtD
Hydrochlorothiazide—Ataxia—Methotrexate—colon cancer	0.00076	0.00171	CcSEcCtD
Hydrochlorothiazide—Rhinitis—Capecitabine—colon cancer	0.000753	0.0017	CcSEcCtD
Hydrochlorothiazide—Hepatitis—Capecitabine—colon cancer	0.000751	0.00169	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Fluorouracil—colon cancer	0.000748	0.00168	CcSEcCtD
Hydrochlorothiazide—Hypoaesthesia—Capecitabine—colon cancer	0.000747	0.00168	CcSEcCtD
Hydrochlorothiazide—Liver function test abnormal—Methotrexate—colon cancer	0.000746	0.00168	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal discomfort—Vincristine—colon cancer	0.000746	0.00168	CcSEcCtD
Hydrochlorothiazide—Pharyngitis—Capecitabine—colon cancer	0.000745	0.00168	CcSEcCtD
Hydrochlorothiazide—Tachycardia—Fluorouracil—colon cancer	0.000745	0.00168	CcSEcCtD
Hydrochlorothiazide—Hypotension—Irinotecan—colon cancer	0.000745	0.00168	CcSEcCtD
Hydrochlorothiazide—Insomnia—Vincristine—colon cancer	0.00074	0.00167	CcSEcCtD
Hydrochlorothiazide—Oedema peripheral—Capecitabine—colon cancer	0.00074	0.00167	CcSEcCtD
Hydrochlorothiazide—Paraesthesia—Vincristine—colon cancer	0.000735	0.00166	CcSEcCtD
Hydrochlorothiazide—Breast disorder—Methotrexate—colon cancer	0.00073	0.00164	CcSEcCtD
Hydrochlorothiazide—Anorexia—Fluorouracil—colon cancer	0.000728	0.00164	CcSEcCtD
Hydrochlorothiazide—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000728	0.00164	CcSEcCtD
Hydrochlorothiazide—Visual impairment—Capecitabine—colon cancer	0.000724	0.00163	CcSEcCtD
Hydrochlorothiazide—Insomnia—Irinotecan—colon cancer	0.000721	0.00162	CcSEcCtD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—NRAS—colon cancer	0.000719	0.00182	CbGpPWpGaD
Hydrochlorothiazide—Paraesthesia—Irinotecan—colon cancer	0.000716	0.00161	CcSEcCtD
Hydrochlorothiazide—Hypotension—Fluorouracil—colon cancer	0.000714	0.00161	CcSEcCtD
Hydrochlorothiazide—Decreased appetite—Vincristine—colon cancer	0.000712	0.0016	CcSEcCtD
Hydrochlorothiazide—Dyspnoea—Irinotecan—colon cancer	0.000711	0.0016	CcSEcCtD
Hydrochlorothiazide—Erythema multiforme—Capecitabine—colon cancer	0.00071	0.0016	CcSEcCtD
Hydrochlorothiazide—Somnolence—Irinotecan—colon cancer	0.000709	0.0016	CcSEcCtD
Hydrochlorothiazide—Fatigue—Vincristine—colon cancer	0.000706	0.00159	CcSEcCtD
Hydrochlorothiazide—Dyspepsia—Irinotecan—colon cancer	0.000702	0.00158	CcSEcCtD
Hydrochlorothiazide—Tinnitus—Capecitabine—colon cancer	0.0007	0.00158	CcSEcCtD
Hydrochlorothiazide—Pain—Vincristine—colon cancer	0.0007	0.00158	CcSEcCtD
Hydrochlorothiazide—Constipation—Vincristine—colon cancer	0.0007	0.00158	CcSEcCtD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—PPARG—colon cancer	0.000698	0.00176	CbGpPWpGaD
Hydrochlorothiazide—Flushing—Capecitabine—colon cancer	0.000697	0.00157	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000696	0.00157	CcSEcCtD
Hydrochlorothiazide—Decreased appetite—Irinotecan—colon cancer	0.000693	0.00156	CcSEcCtD
Hydrochlorothiazide—Insomnia—Fluorouracil—colon cancer	0.000691	0.00156	CcSEcCtD
Hydrochlorothiazide—Fatigue—Irinotecan—colon cancer	0.000687	0.00155	CcSEcCtD
Hydrochlorothiazide—Paraesthesia—Fluorouracil—colon cancer	0.000686	0.00154	CcSEcCtD
Hydrochlorothiazide—Pancreatitis—Methotrexate—colon cancer	0.000685	0.00154	CcSEcCtD
Hydrochlorothiazide—Constipation—Irinotecan—colon cancer	0.000682	0.00154	CcSEcCtD
Hydrochlorothiazide—Pain—Irinotecan—colon cancer	0.000682	0.00154	CcSEcCtD
Hydrochlorothiazide—Dyspnoea—Fluorouracil—colon cancer	0.000681	0.00153	CcSEcCtD
Hydrochlorothiazide—Somnolence—Fluorouracil—colon cancer	0.000679	0.00153	CcSEcCtD
Hydrochlorothiazide—Dyspepsia—Fluorouracil—colon cancer	0.000672	0.00151	CcSEcCtD
Hydrochlorothiazide—Arrhythmia—Capecitabine—colon cancer	0.000671	0.00151	CcSEcCtD
Hydrochlorothiazide—CA4—Metabolism—ODC1—colon cancer	0.00067	0.00169	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—CHST5—colon cancer	0.00067	0.00169	CbGpPWpGaD
Hydrochlorothiazide—Gastrointestinal pain—Vincristine—colon cancer	0.000669	0.00151	CcSEcCtD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—MYC—colon cancer	0.000669	0.00169	CbGpPWpGaD
Hydrochlorothiazide—Decreased appetite—Fluorouracil—colon cancer	0.000664	0.00149	CcSEcCtD
Hydrochlorothiazide—Alopecia—Capecitabine—colon cancer	0.000664	0.00149	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Irinotecan—colon cancer	0.000657	0.00148	CcSEcCtD
Hydrochlorothiazide—Erythema—Capecitabine—colon cancer	0.000654	0.00147	CcSEcCtD
Hydrochlorothiazide—Neutropenia—Methotrexate—colon cancer	0.000653	0.00147	CcSEcCtD
Hydrochlorothiazide—Dysuria—Methotrexate—colon cancer	0.000653	0.00147	CcSEcCtD
Hydrochlorothiazide—Pain—Fluorouracil—colon cancer	0.000653	0.00147	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal pain—Irinotecan—colon cancer	0.000652	0.00147	CcSEcCtD
Hydrochlorothiazide—Upper respiratory tract infection—Methotrexate—colon cancer	0.000649	0.00146	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Vincristine—colon cancer	0.000647	0.00146	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Vincristine—colon cancer	0.000647	0.00146	CcSEcCtD
Hydrochlorothiazide—Flatulence—Capecitabine—colon cancer	0.000644	0.00145	CcSEcCtD
Hydrochlorothiazide—Erectile dysfunction—Methotrexate—colon cancer	0.000643	0.00145	CcSEcCtD
Hydrochlorothiazide—CA2—Metabolism—ODC1—colon cancer	0.000642	0.00162	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—CHST5—colon cancer	0.000642	0.00162	CbGpPWpGaD
Hydrochlorothiazide—Dysgeusia—Capecitabine—colon cancer	0.00064	0.00144	CcSEcCtD
Hydrochlorothiazide—Photosensitivity reaction—Methotrexate—colon cancer	0.000638	0.00144	CcSEcCtD
Hydrochlorothiazide—Back pain—Capecitabine—colon cancer	0.000632	0.00142	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Irinotecan—colon cancer	0.00063	0.00142	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Irinotecan—colon cancer	0.00063	0.00142	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Fluorouracil—colon cancer	0.000629	0.00142	CcSEcCtD
Hydrochlorothiazide—Muscle spasms—Capecitabine—colon cancer	0.000629	0.00142	CcSEcCtD
Hydrochlorothiazide—Pneumonia—Methotrexate—colon cancer	0.000626	0.00141	CcSEcCtD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—KRAS—colon cancer	0.000618	0.00156	CbGpPWpGaD
Hydrochlorothiazide—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000617	0.00139	CcSEcCtD
Hydrochlorothiazide—Vision blurred—Capecitabine—colon cancer	0.000616	0.00139	CcSEcCtD
Hydrochlorothiazide—CA1—Metabolism—CHST5—colon cancer	0.000616	0.00156	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—ODC1—colon cancer	0.000616	0.00156	CbGpPWpGaD
Hydrochlorothiazide—Tremor—Capecitabine—colon cancer	0.000613	0.00138	CcSEcCtD
Hydrochlorothiazide—Renal failure—Methotrexate—colon cancer	0.000612	0.00138	CcSEcCtD
Hydrochlorothiazide—Ill-defined disorder—Capecitabine—colon cancer	0.000607	0.00137	CcSEcCtD
Hydrochlorothiazide—Urticaria—Fluorouracil—colon cancer	0.000607	0.00137	CcSEcCtD
Hydrochlorothiazide—Conjunctivitis—Methotrexate—colon cancer	0.000605	0.00136	CcSEcCtD
Hydrochlorothiazide—Anaemia—Capecitabine—colon cancer	0.000604	0.00136	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Fluorouracil—colon cancer	0.000604	0.00136	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Vincristine—colon cancer	0.000603	0.00136	CcSEcCtD
Hydrochlorothiazide—Sweating—Methotrexate—colon cancer	0.000597	0.00134	CcSEcCtD
Hydrochlorothiazide—Haematuria—Methotrexate—colon cancer	0.000594	0.00134	CcSEcCtD
Hydrochlorothiazide—Malaise—Capecitabine—colon cancer	0.00059	0.00133	CcSEcCtD
Hydrochlorothiazide—Epistaxis—Methotrexate—colon cancer	0.000587	0.00132	CcSEcCtD
Hydrochlorothiazide—Vertigo—Capecitabine—colon cancer	0.000587	0.00132	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Irinotecan—colon cancer	0.000587	0.00132	CcSEcCtD
Hydrochlorothiazide—Asthenia—Vincristine—colon cancer	0.000587	0.00132	CcSEcCtD
Hydrochlorothiazide—Syncope—Capecitabine—colon cancer	0.000586	0.00132	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Capecitabine—colon cancer	0.000585	0.00132	CcSEcCtD
Hydrochlorothiazide—Agranulocytosis—Methotrexate—colon cancer	0.000581	0.00131	CcSEcCtD
Hydrochlorothiazide—Palpitations—Capecitabine—colon cancer	0.000578	0.0013	CcSEcCtD
Hydrochlorothiazide—Loss of consciousness—Capecitabine—colon cancer	0.000575	0.00129	CcSEcCtD
Hydrochlorothiazide—Asthenia—Irinotecan—colon cancer	0.000572	0.00129	CcSEcCtD
Hydrochlorothiazide—Cough—Capecitabine—colon cancer	0.000571	0.00128	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Fluorouracil—colon cancer	0.000563	0.00127	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Vincristine—colon cancer	0.00056	0.00126	CcSEcCtD
Hydrochlorothiazide—Hepatitis—Methotrexate—colon cancer	0.000559	0.00126	CcSEcCtD
Hydrochlorothiazide—Chest pain—Capecitabine—colon cancer	0.000557	0.00125	CcSEcCtD
Hydrochlorothiazide—Arthralgia—Capecitabine—colon cancer	0.000557	0.00125	CcSEcCtD
Hydrochlorothiazide—Myalgia—Capecitabine—colon cancer	0.000557	0.00125	CcSEcCtD
Hydrochlorothiazide—Pharyngitis—Methotrexate—colon cancer	0.000555	0.00125	CcSEcCtD
Hydrochlorothiazide—Anxiety—Capecitabine—colon cancer	0.000555	0.00125	CcSEcCtD
Hydrochlorothiazide—Discomfort—Capecitabine—colon cancer	0.00055	0.00124	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Irinotecan—colon cancer	0.000545	0.00123	CcSEcCtD
Hydrochlorothiazide—Dry mouth—Capecitabine—colon cancer	0.000544	0.00123	CcSEcCtD
Hydrochlorothiazide—Dizziness—Vincristine—colon cancer	0.000541	0.00122	CcSEcCtD
Hydrochlorothiazide—CA9—Metabolism—CHST5—colon cancer	0.000541	0.00137	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—ODC1—colon cancer	0.000541	0.00137	CbGpPWpGaD
Hydrochlorothiazide—Pruritus—Fluorouracil—colon cancer	0.00054	0.00122	CcSEcCtD
Hydrochlorothiazide—Visual impairment—Methotrexate—colon cancer	0.000539	0.00121	CcSEcCtD
Hydrochlorothiazide—Confusional state—Capecitabine—colon cancer	0.000538	0.00121	CcSEcCtD
Hydrochlorothiazide—Oedema—Capecitabine—colon cancer	0.000534	0.0012	CcSEcCtD
Hydrochlorothiazide—Erythema multiforme—Methotrexate—colon cancer	0.000529	0.00119	CcSEcCtD
Hydrochlorothiazide—Dizziness—Irinotecan—colon cancer	0.000527	0.00119	CcSEcCtD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—HRAS—colon cancer	0.000526	0.00133	CbGpPWpGaD
Hydrochlorothiazide—Shock—Capecitabine—colon cancer	0.000525	0.00118	CcSEcCtD
Hydrochlorothiazide—KCNMA1—Neuronal System—BRAF—colon cancer	0.000523	0.00132	CbGpPWpGaD
Hydrochlorothiazide—Diarrhoea—Fluorouracil—colon cancer	0.000522	0.00118	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Capecitabine—colon cancer	0.000522	0.00118	CcSEcCtD
Hydrochlorothiazide—Tinnitus—Methotrexate—colon cancer	0.000521	0.00117	CcSEcCtD
Hydrochlorothiazide—Tachycardia—Capecitabine—colon cancer	0.000521	0.00117	CcSEcCtD
Hydrochlorothiazide—Vomiting—Vincristine—colon cancer	0.000521	0.00117	CcSEcCtD
Hydrochlorothiazide—Rash—Vincristine—colon cancer	0.000516	0.00116	CcSEcCtD
Hydrochlorothiazide—Hyperhidrosis—Capecitabine—colon cancer	0.000516	0.00116	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Vincristine—colon cancer	0.000516	0.00116	CcSEcCtD
Hydrochlorothiazide—Headache—Vincristine—colon cancer	0.000513	0.00115	CcSEcCtD
Hydrochlorothiazide—Anorexia—Capecitabine—colon cancer	0.000509	0.00115	CcSEcCtD
Hydrochlorothiazide—Vomiting—Irinotecan—colon cancer	0.000507	0.00114	CcSEcCtD
Hydrochlorothiazide—Dizziness—Fluorouracil—colon cancer	0.000505	0.00114	CcSEcCtD
Hydrochlorothiazide—Rash—Irinotecan—colon cancer	0.000503	0.00113	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Irinotecan—colon cancer	0.000502	0.00113	CcSEcCtD
Hydrochlorothiazide—Headache—Irinotecan—colon cancer	0.000499	0.00112	CcSEcCtD
Hydrochlorothiazide—Hypotension—Capecitabine—colon cancer	0.000499	0.00112	CcSEcCtD
Hydrochlorothiazide—CA9—HIF-1-alpha transcription factor network—AKT1—colon cancer	0.000495	0.00125	CbGpPWpGaD
Hydrochlorothiazide—Alopecia—Methotrexate—colon cancer	0.000494	0.00111	CcSEcCtD
Hydrochlorothiazide—Erythema—Methotrexate—colon cancer	0.000487	0.0011	CcSEcCtD
Hydrochlorothiazide—Nausea—Vincristine—colon cancer	0.000486	0.00109	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000486	0.00109	CcSEcCtD
Hydrochlorothiazide—Vomiting—Fluorouracil—colon cancer	0.000485	0.00109	CcSEcCtD
Hydrochlorothiazide—Insomnia—Capecitabine—colon cancer	0.000483	0.00109	CcSEcCtD
Hydrochlorothiazide—Rash—Fluorouracil—colon cancer	0.000481	0.00108	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Fluorouracil—colon cancer	0.000481	0.00108	CcSEcCtD
Hydrochlorothiazide—Paraesthesia—Capecitabine—colon cancer	0.000479	0.00108	CcSEcCtD
Hydrochlorothiazide—Headache—Fluorouracil—colon cancer	0.000478	0.00108	CcSEcCtD
Hydrochlorothiazide—Dysgeusia—Methotrexate—colon cancer	0.000477	0.00107	CcSEcCtD
Hydrochlorothiazide—Dyspnoea—Capecitabine—colon cancer	0.000476	0.00107	CcSEcCtD
Hydrochlorothiazide—Nausea—Irinotecan—colon cancer	0.000474	0.00107	CcSEcCtD
Hydrochlorothiazide—Back pain—Methotrexate—colon cancer	0.000471	0.00106	CcSEcCtD
Hydrochlorothiazide—Dyspepsia—Capecitabine—colon cancer	0.00047	0.00106	CcSEcCtD
Hydrochlorothiazide—Decreased appetite—Capecitabine—colon cancer	0.000464	0.00104	CcSEcCtD
Hydrochlorothiazide—Fatigue—Capecitabine—colon cancer	0.00046	0.00104	CcSEcCtD
Hydrochlorothiazide—Vision blurred—Methotrexate—colon cancer	0.000459	0.00103	CcSEcCtD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—EP300—colon cancer	0.000457	0.00115	CbGpPWpGaD
Hydrochlorothiazide—Constipation—Capecitabine—colon cancer	0.000456	0.00103	CcSEcCtD
Hydrochlorothiazide—Pain—Capecitabine—colon cancer	0.000456	0.00103	CcSEcCtD
Hydrochlorothiazide—Nausea—Fluorouracil—colon cancer	0.000454	0.00102	CcSEcCtD
Hydrochlorothiazide—Ill-defined disorder—Methotrexate—colon cancer	0.000452	0.00102	CcSEcCtD
Hydrochlorothiazide—Anaemia—Methotrexate—colon cancer	0.00045	0.00101	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Capecitabine—colon cancer	0.00044	0.00099	CcSEcCtD
Hydrochlorothiazide—Malaise—Methotrexate—colon cancer	0.000439	0.000988	CcSEcCtD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000438	0.00111	CbGpPWpGaD
Hydrochlorothiazide—Vertigo—Methotrexate—colon cancer	0.000437	0.000985	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal pain—Capecitabine—colon cancer	0.000436	0.000983	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Methotrexate—colon cancer	0.000436	0.000981	CcSEcCtD
Hydrochlorothiazide—Cough—Methotrexate—colon cancer	0.000425	0.000956	CcSEcCtD
Hydrochlorothiazide—Urticaria—Capecitabine—colon cancer	0.000424	0.000955	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Capecitabine—colon cancer	0.000422	0.00095	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Capecitabine—colon cancer	0.000422	0.00095	CcSEcCtD
Hydrochlorothiazide—Myalgia—Methotrexate—colon cancer	0.000414	0.000933	CcSEcCtD
Hydrochlorothiazide—Arthralgia—Methotrexate—colon cancer	0.000414	0.000933	CcSEcCtD
Hydrochlorothiazide—Chest pain—Methotrexate—colon cancer	0.000414	0.000933	CcSEcCtD
Hydrochlorothiazide—Discomfort—Methotrexate—colon cancer	0.000409	0.000922	CcSEcCtD
Hydrochlorothiazide—Confusional state—Methotrexate—colon cancer	0.000401	0.000902	CcSEcCtD
Hydrochlorothiazide—Anaphylactic shock—Methotrexate—colon cancer	0.000397	0.000894	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Capecitabine—colon cancer	0.000393	0.000885	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Methotrexate—colon cancer	0.000389	0.000876	CcSEcCtD
Hydrochlorothiazide—Hyperhidrosis—Methotrexate—colon cancer	0.000384	0.000865	CcSEcCtD
Hydrochlorothiazide—Asthenia—Capecitabine—colon cancer	0.000383	0.000862	CcSEcCtD
Hydrochlorothiazide—Anorexia—Methotrexate—colon cancer	0.000379	0.000853	CcSEcCtD
Hydrochlorothiazide—Pruritus—Capecitabine—colon cancer	0.000378	0.00085	CcSEcCtD
Hydrochlorothiazide—Hypotension—Methotrexate—colon cancer	0.000371	0.000836	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Capecitabine—colon cancer	0.000365	0.000822	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000362	0.000815	CcSEcCtD
Hydrochlorothiazide—Insomnia—Methotrexate—colon cancer	0.000359	0.000809	CcSEcCtD
Hydrochlorothiazide—Paraesthesia—Methotrexate—colon cancer	0.000357	0.000803	CcSEcCtD
Hydrochlorothiazide—Dyspnoea—Methotrexate—colon cancer	0.000354	0.000797	CcSEcCtD
Hydrochlorothiazide—Somnolence—Methotrexate—colon cancer	0.000353	0.000795	CcSEcCtD
Hydrochlorothiazide—Dizziness—Capecitabine—colon cancer	0.000353	0.000795	CcSEcCtD
Hydrochlorothiazide—Dyspepsia—Methotrexate—colon cancer	0.00035	0.000787	CcSEcCtD
Hydrochlorothiazide—Decreased appetite—Methotrexate—colon cancer	0.000345	0.000778	CcSEcCtD
Hydrochlorothiazide—Fatigue—Methotrexate—colon cancer	0.000342	0.000771	CcSEcCtD
Hydrochlorothiazide—Pain—Methotrexate—colon cancer	0.00034	0.000765	CcSEcCtD
Hydrochlorothiazide—Vomiting—Capecitabine—colon cancer	0.000339	0.000764	CcSEcCtD
Hydrochlorothiazide—Rash—Capecitabine—colon cancer	0.000336	0.000758	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Capecitabine—colon cancer	0.000336	0.000757	CcSEcCtD
Hydrochlorothiazide—Headache—Capecitabine—colon cancer	0.000334	0.000753	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Methotrexate—colon cancer	0.000327	0.000737	CcSEcCtD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—TP53—colon cancer	0.000327	0.000826	CbGpPWpGaD
Hydrochlorothiazide—Gastrointestinal pain—Methotrexate—colon cancer	0.000325	0.000731	CcSEcCtD
Hydrochlorothiazide—Nausea—Capecitabine—colon cancer	0.000317	0.000714	CcSEcCtD
Hydrochlorothiazide—Urticaria—Methotrexate—colon cancer	0.000316	0.000711	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Methotrexate—colon cancer	0.000314	0.000707	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Methotrexate—colon cancer	0.000314	0.000707	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Methotrexate—colon cancer	0.000293	0.000659	CcSEcCtD
Hydrochlorothiazide—Asthenia—Methotrexate—colon cancer	0.000285	0.000642	CcSEcCtD
Hydrochlorothiazide—CA9—Cellular responses to stress—CDKN1A—colon cancer	0.000284	0.000718	CbGpPWpGaD
Hydrochlorothiazide—Pruritus—Methotrexate—colon cancer	0.000281	0.000633	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Methotrexate—colon cancer	0.000272	0.000612	CcSEcCtD
Hydrochlorothiazide—CA9—Cellular responses to stress—EP300—colon cancer	0.00027	0.000683	CbGpPWpGaD
Hydrochlorothiazide—Dizziness—Methotrexate—colon cancer	0.000263	0.000591	CcSEcCtD
Hydrochlorothiazide—CA9—Cellular responses to stress—VEGFA—colon cancer	0.000256	0.000647	CbGpPWpGaD
Hydrochlorothiazide—Vomiting—Methotrexate—colon cancer	0.000253	0.000569	CcSEcCtD
Hydrochlorothiazide—Rash—Methotrexate—colon cancer	0.00025	0.000564	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Methotrexate—colon cancer	0.00025	0.000563	CcSEcCtD
Hydrochlorothiazide—Headache—Methotrexate—colon cancer	0.000249	0.00056	CcSEcCtD
Hydrochlorothiazide—KCNMA1—Neuronal System—HRAS—colon cancer	0.000241	0.000608	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—ABCB1—colon cancer	0.00024	0.000605	CbGpPWpGaD
Hydrochlorothiazide—Nausea—Methotrexate—colon cancer	0.000236	0.000531	CcSEcCtD
Hydrochlorothiazide—CA5B—Metabolism—TYMS—colon cancer	0.000235	0.000595	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—ABCB1—colon cancer	0.000222	0.000561	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—EP300—colon cancer	0.000218	0.000552	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—TYMS—colon cancer	0.000218	0.000551	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—SRC—colon cancer	0.000212	0.000536	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—VEGFA—colon cancer	0.000207	0.000522	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—NRAS—colon cancer	0.000204	0.000516	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—TP53—colon cancer	0.000193	0.000489	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—TGFB1—colon cancer	0.00019	0.00048	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000183	0.000463	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—ABCB1—colon cancer	0.000177	0.000447	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—KRAS—colon cancer	0.000176	0.000444	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—TYMS—colon cancer	0.000174	0.000439	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—ABCB1—colon cancer	0.00017	0.000429	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PPARG—colon cancer	0.000167	0.000421	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—TYMS—colon cancer	0.000167	0.000421	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—ABCB1—colon cancer	0.000163	0.000411	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—PIK3CA—colon cancer	0.000161	0.000408	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—TYMS—colon cancer	0.00016	0.000404	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—TP53—colon cancer	0.000156	0.000395	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PPARG—colon cancer	0.000154	0.00039	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—HRAS—colon cancer	0.000149	0.000378	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—ABCB1—colon cancer	0.000143	0.000361	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—TYMS—colon cancer	0.00014	0.000355	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—AKT1—colon cancer	0.000132	0.000333	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PTGS2—colon cancer	0.000131	0.000331	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PPARG—colon cancer	0.000123	0.000311	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PTGS2—colon cancer	0.000121	0.000307	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PPARG—colon cancer	0.000118	0.000298	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PPARG—colon cancer	0.000113	0.000286	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—EP300—colon cancer	0.000109	0.000276	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—EP300—colon cancer	0.000101	0.000255	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PPARG—colon cancer	9.95e-05	0.000251	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PTGS2—colon cancer	9.68e-05	0.000245	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PTGS2—colon cancer	9.29e-05	0.000235	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PTGS2—colon cancer	8.9e-05	0.000225	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PIK3CA—colon cancer	8.07e-05	0.000204	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—EP300—colon cancer	8.05e-05	0.000204	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PTGS2—colon cancer	7.83e-05	0.000198	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—EP300—colon cancer	7.72e-05	0.000195	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PIK3CA—colon cancer	7.47e-05	0.000189	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—EP300—colon cancer	7.4e-05	0.000187	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—AKT1—colon cancer	6.59e-05	0.000167	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—EP300—colon cancer	6.51e-05	0.000164	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—AKT1—colon cancer	6.1e-05	0.000154	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PIK3CA—colon cancer	5.96e-05	0.000151	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PIK3CA—colon cancer	5.71e-05	0.000144	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PIK3CA—colon cancer	5.48e-05	0.000138	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—AKT1—colon cancer	4.87e-05	0.000123	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PIK3CA—colon cancer	4.81e-05	0.000122	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—AKT1—colon cancer	4.67e-05	0.000118	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—AKT1—colon cancer	4.47e-05	0.000113	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—AKT1—colon cancer	3.93e-05	9.94e-05	CbGpPWpGaD
